University of Wisconsin Foundation
EndowmentFiling Date
Global Rank
#7,885
/ 8,794
▼ 473
· as of Jun 2026
Top Industry
Biotechnology
33.3%
3Y Alpha vs SPY
+17.2%
Period ended 3 months ago
Filed Aug 14, 2026 · 51d
15 quarters · since Dec 2022
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
9 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
22.8%
+9.2 pts
Top 5
71.0%
+13.0 pts
Top 10
100.0%
0.0 pts
HHI
1,328
Diversified+283
Portfolio Trend
15 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 25.8% | $32,528,010 |
| Unclassified | 22.8% | $28,752,905 |
| Financial Services | 22.4% | $28,249,429 |
| Technology | 22.0% | $27,779,763 |
| Communication Services | 7.1% | $8,989,284 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PRAX | Praxis Precision Medicines, Inc. | +9,515 | 34,730 | $11,627,256 | |
| No positions match the current search. | |||||
9 tracked positions ·
$126,299,391 total
· filing declares
9 positions · $126,299,395
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AFK |
VanEck Africa Index ETF
|
NEW | 43,838 | $28,752,905 | 22.77% | |
| CBRS |
Cerebras Systems Inc.
Technology
|
NEW | 84,911 | $18,765,331 | 14.86% | |
| PDCC |
Pearl Diver Credit Co Inc.
Financial Services
|
Held | 1,459,021 | $14,531,849 | 11.51% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Held | 239,749 | $13,936,609 | 11.03% | |
| NU |
Nu Holdings Ltd.
Financial Services
|
Held | 1,026,765 | $13,717,580 | 10.86% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 34,730 | $11,627,256 | 9.21% | |
| AAPL |
Apple Inc.
Technology
|
Reduced | 31,153 | $9,014,432 | 7.14% | |
| GOOGL |
Alphabet Inc.
Communication Services
|
Reduced | 25,154 | $8,989,284 | 7.12% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 313,559 | $6,964,145 | 5.51% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.